Bioscience

CU: New technology diagnoses sickle cell blood disease in record time

CU: New technology diagnoses sickle cell blood disease in record time

BOULDER -- Researchers at the University of Colorado Boulder and the University of Colorado Anschutz Medical Campus have developed a new way to diagnose diseases of the blood like sickle cell disease... Read More

Friday October 16, 2020 0 comments Tags: Boulder, CU Boulder, Angelo D'Alessandro, Xiaoyun Ding, Michael Stowell, Kerri Ball

Summit Biolabs, Center for Personalized Medicine to develop saliva tests for COVID, head & neck cancer

Summit Biolabs, Center for Personalized Medicine to develop saliva tests for COVID, head & neck cancer

AURORA -- Summit Biolabs, Inc. , an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head neck cancer, and the Colorado Center for Personalized... Read More

Thursday October 15, 2020 0 comments Tags: Aurora, Summit Biolabs, COVID-19, Colorado Center for Personalized Medicine, Kathleen Barnes, Bob Blomquist

Reven selects eClinical services provider DSG to accelerate Reven’s RJX as treatment for COVID-19

Reven selects eClinical services provider DSG to accelerate Reven’s RJX as treatment for COVID-19

GOLDEN -- Reven Holdings, Inc. today announced it selected DSG, Inc., a leading global eClinical services provider, for all aspects of clinical trial data management during its upcoming COVID-19... Read More

Wednesday September 30, 2020 0 comments Tags: Golden, Reven Holdings, Reven Pharmaceuticals, DSG, Fatih Uckun, Michael Volk, Tony Varano, COVID-19

TriSalus Life Sciences lays out therapeutic strategy upon acquisition of first therapeutic candidate

TriSalus Life Sciences lays out therapeutic strategy upon acquisition of first therapeutic candidate

DENVER and CHICAGO -- TriSalus Life Sciences (TriSalus), an emerging immune-oncology company committed to transforming outcomes for patients with solid tumors, announced its therapeutic clinical... Read More

Monday September 28, 2020 0 comments Tags: Westminster, TriSalus Life Sciences, SD-101, Mats Wahlstrom, Mary Szela, Steven Katz

CSU secures $3.1 million from NIH to advance SolaVAX coronavirus vaccine research

CSU secures $3.1 million from NIH to advance SolaVAX coronavirus vaccine research

FORT COLLINS -- A team of scientists at Colorado State University was awarded a base contract worth $3.1 million from the National Institutes of Health to continue development... Read More

Tuesday September 22, 2020 0 comments Tags: Fort Collins, CSU, COVID-19, NIH, SolaVAX, Ray Goodrich, CSU Infectious Disease Research Center , CSU BioMARC

FDA grants IND and approves clinical trial protocol of inhaled Ampion for COVID-19 patients

FDA grants IND and approves clinical trial protocol of inhaled Ampion for COVID-19 patients

ENGLEWOOD-- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced it has received an Investigational New Drug designation from the U.S. Food and Drug Administration, allowing the company to... Read More

Monday September 21, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19, FDA

CBSA sets virtual Life Sciences Innovation Forum for Sept. 30-Oct. 1

CBSA sets virtual Life Sciences Innovation Forum for Sept. 30-Oct. 1

Colorado BioScience Association will host a virtual Life Sciences Innovation Forum and Trade Show in two half-day interactive sessions on Sept. 30 and Oct. 1. The event will feature a... Read More

Friday September 18, 2020 0 comments Tags: CBSA, CBSA Life Science Innovation Forum

CSU chemist seeks to build a better way to make COVID-19 drug, using light

CSU chemist seeks to build a better way to make COVID-19 drug, using light

FORT COLLINS -- As the novel coronavirus continues to sicken tens of thousands of people a day in the United States, scientists have found that the antiviral medication remdesivir can... Read More

Friday September 18, 2020 0 comments Tags: Fort Collins, CSU, COVID-19, Garret Miyake, New Iridium, Chern Hooi Lim, remdesivir